Currently predicting for Fri, 5 Jun 2026

GILD Prediction Chart

GILD Predictions History

Latest community submissions for GILD.
Predictor Target Session Target Price Result Direction Accuracy Score
Dec 23, 2024 $91.74 -0.90% $93.40 X 98.22% 0
Dec 23, 2024 $92.05 -0.56% $93.40 X 98.56% 1
Dec 23, 2024 Bullish $93.40 V 1
Sep 26, 2024 $82.82 +0.74% $83.04 V 99.74% 5
Sep 26, 2024 $82.59 +0.47% $83.04 V 99.46% 4
Sep 26, 2024 $86.00 +4.61% $83.04 V 96.44% 1
AlexVel AlexVel Pro
Mar 7, 2022 $61.58 -0.45% $61.86 X 99.55% 4
JS JS Pro
Mar 7, 2022 $61.52 -0.55% $61.86 X 99.45% 3
Mar 7, 2022 $67.11 +8.49% $61.86 X 91.51% 0
Aug 31, 2021 $73.00 +0.30% $72.78 X 99.70% 5
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for GILD with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT GILEAD SCIENCES
Gilead
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, V...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE